PRDM2 and cancer: In both GC-1 mouse spermatogonial normal cell line and in TCam-2 human spermatogonial cancer cell line (Figure 1, panel A or B, respectively), treatment with proliferation-inducing agents modulated the relative ratio between the major transcripts coded by PRDM2 gene.